Frost & Sullivan Award Winner for RFID Enabled Contrast Delivery System + RFID Enabled UltrajetTM Prefilled Syringe
Optivantage™ dual-head CT contrast delivery system is the first with RFID-enabled intelligence to help safeguard against certain life threatening medical errors.
The Optivantage™ dual-head CT contrast delivery system brings the innovation of RFID (Radio Frequency Identification) technology to patient point of care in the CT suite. RFID technology is an automatic identification technology that captures, stores, and transmits data using devices called RFID tags or transponders. The RFID-enabled Optivantage™ contrast delivery system combined with the use of RFID-enabled Ultraject™ prefilled syringes prevents accidental air embolism caused from using an empty, used syringe. The unique, user-friendly powerhead provides a color LCD screen that is fully programmable at the patient’s side, allowing technologists to perform a saline flush, change protocols, fill syringes and much more with just the touch of a button. The injection system accommodates both 125 mL Ultraject™ prefilled syringes and 200 mL disposable syringes, with easy front loading and removal.
The Optivantage™ dual-head CT contrast delivery system provides an upgradeable platform to which new technology may be added as it becomes available.
This contrast delivery system with RFID technology is the recipient of the 2008 Frost & Sullivan North American Product Innovation Award in the field of RFID based biological delivery systems. The news release from Frost and Sullivan is available for more details on the award by clicking the document on the right.